Beurs gesloten -
Japan Exchange
08:00:00 06-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
711
JPY
|
-1,93%
|
|
+6,76%
|
-5,45%
|
Fiscaal tijdperk: September |
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
3.919
|
2.421
|
4.318
|
Bedrijfswaarde
1 |
1.782
|
-334,7
|
2.182
|
K/w-verhouding
|
-12,5
x
|
-6,6
x
|
-5,04
x
|
Dividendrendement
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
13.560.121
x
|
6.192.521
x
|
62.574.916
x
|
Bedrijfswaarde/omzet
|
6.165.657
x
|
-856.072
x
|
31.618.394
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-3.523.233
x
|
1.806.878
x
|
-4.050.442
x
|
FCF Yield
|
-0%
|
0%
|
-0%
|
Price to Book
|
1,57
x
|
0,87
x
|
2,13
x
|
Aantal aandelen (in duizenden)
|
4.321
|
5.381
|
5.411
|
Referentieprijs
2 |
907,0
|
450,0
|
798,0
|
Datum van publicatie
|
27-12-21
|
26-12-22
|
25-12-23
|
Fiscaal tijdperk: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
|
-
|
-
|
467
|
289
|
391
|
69
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-223
|
-371
|
-172
|
-358
|
-426
|
-889
|
Operationele Marge
|
-
|
-
|
-36,83%
|
-123,88%
|
-108,95%
|
-1.288,41%
|
Resultaat voor belastingen (EBT)
1 |
-64
|
-302
|
-116
|
-300
|
-330
|
-853
|
Nettowinst (verlies)
1 |
-64
|
-302
|
-117
|
-301
|
-331
|
-854
|
Nettomarge
|
-
|
-
|
-25,05%
|
-104,15%
|
-84,65%
|
-1.237,68%
|
WPA
2 |
-61,48
|
-290,1
|
-105,9
|
-72,47
|
-68,16
|
-158,4
|
Free Cash Flow
|
-
|
-
|
-
|
-505,8
|
-185,2
|
-538,6
|
FCF-marge
|
-
|
-
|
-
|
-175%
|
-47,38%
|
-780,62%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
24-11-20
|
24-11-20
|
24-11-20
|
27-12-21
|
26-12-22
|
25-12-23
|
Fiscaal tijdperk: September |
2020 S1
|
2021 S1
|
2022 Q1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
---|
Omzet
1 |
-
|
117
|
13
|
27
|
85
|
17
|
34
|
17
|
18
|
43
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-169
|
-120
|
-310
|
-73
|
-157
|
-314
|
-306
|
-168
|
-366
|
Operationele Marge
|
-
|
-144,44%
|
-923,08%
|
-1.148,15%
|
-85,88%
|
-923,53%
|
-923,53%
|
-1.800%
|
-933,33%
|
-851,16%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-191
|
-128
|
-318
|
13
|
-157
|
-314
|
-263
|
-169
|
-365
|
Nettowinst (verlies)
1 |
-
|
-192
|
-129
|
-319
|
13
|
-157
|
-315
|
-263
|
-169
|
-366
|
Nettomarge
|
-
|
-164,1%
|
-992,31%
|
-1.181,48%
|
15,29%
|
-923,53%
|
-926,47%
|
-1.547,06%
|
-938,89%
|
-851,16%
|
WPA
2 |
-
|
-48,33
|
-29,02
|
-70,24
|
5,220
|
-29,34
|
-58,63
|
-48,82
|
-29,53
|
-60,21
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
-
|
14-05-21
|
14-02-22
|
13-05-22
|
12-08-22
|
10-02-23
|
15-05-23
|
14-08-23
|
09-02-24
|
13-05-24
|
Fiscaal tijdperk: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
505
|
166
|
2.102
|
2.137
|
2.756
|
2.136
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-506
|
-185
|
-539
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-82,3%
|
-9,73%
|
-12,8%
|
-12,5%
|
-35,5%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-56,8%
|
-8,27%
|
-8,98%
|
-9,11%
|
-19,1%
|
Totale activa
1 |
-
|
532
|
1.415
|
3.353
|
3.632
|
4.477
|
Nettoactief per aandeel
2 |
498,0
|
207,0
|
1.691
|
578,0
|
518,0
|
374,0
|
Cashflow per aandeel
2 |
485,0
|
159,0
|
1.624
|
493,0
|
512,0
|
395,0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
24-11-20
|
24-11-20
|
24-11-20
|
27-12-21
|
26-12-22
|
25-12-23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -5,45% | 31,57 mln. | | +57,12% | 59,34 mld. | | +43,17% | 40,24 mld. | | -5,05% | 39,88 mld. | | -5,56% | 28,55 mld. | | +14,95% | 27,26 mld. | | -21,57% | 19,23 mld. | | +32,17% | 12,61 mld. | | +2,02% | 12,49 mld. | | +25,90% | 12,28 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|